IPO Boutique

Cancer Genetics IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Cancer Genetics, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Cancer GeneticsCGIX -
NASDAQ
$10.00-$12.00 $10.00 $10.00600 Thousand4/5/2013
Aegis Capital Corp, Feltl & Co.
Co-Manager(s):
Health Care
Filing(s):

Filed 2011-12-30



Cancer Genetics Quote & Chart - Click for current quote - CGIX

About Cancer Genetics (adapted from Cancer Genetics prospectus):
They are a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment (theranosis) of cancer.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "CGIX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved